Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2012, Article ID 794762, 10 pages
http://dx.doi.org/10.1155/2012/794762
Review Article

Depression in Patients with Cardiovascular Disease

1TEI of Lamia, Lamia, Greece
2Department of Cardiology, Larissa University Hospital, P.O. Box 1425, 411 10 Larissa, Greece
3Department of Neurology, Larissa University Hospital, 411 10 Larissa, Greece
4Department of Cardiovascular and Thoracic Surgery, Larissa University Hospital, 411 10 Larissa, Greece
5Department of Nuclear Medicine, Larissa University Hospital, 411 10 Larissa, Greece
6Department of Psychiatry, Larissa University Hospital, 411 10 Larissa, Greece
7Department of Vascular Surgery, Larissa University Hospital, 411 10 Larissa, Greece
8Nursing Department Bʼ, TEI of Athens, Athens, Greece
9Division of Cardiology, Emory University Hospital, Atlanta, GA, USA

Received 13 March 2012; Accepted 8 May 2012

Academic Editor: George Giannakoulas

Copyright © 2012 Dimos Mastrogiannis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. M. Carney, M. W. Rich, K. E. Freedland et al., “Major depressive disorder predicts cardiac events in patients with coronary artery disease,” Psychosomatic Medicine, vol. 50, no. 6, pp. 627–633, 1988. View at Google Scholar · View at Scopus
  2. C. Trelawny-Ross and O. Russell, “Social and psychological responses to myocardial infarction: multiple determinants of outcome at six months,” Journal of Psychosomatic Research, vol. 31, no. 1, pp. 125–130, 1987. View at Google Scholar · View at Scopus
  3. F. Lespérance, N. Frasure-Smith, M. Juneau, and P. Théroux, “Depression and 1-year prognosis in unstable angina,” Archives of Internal Medicine, vol. 160, no. 9, pp. 1354–1360, 2000. View at Google Scholar · View at Scopus
  4. P. A. Pirraglia, J. C. Peterson, P. Williams-Russo, L. Gorkin, and M. E. Charlson, “Depressive symptomatology in coronary artery bypass graft surgery patients,” International Journal of Geriatric Psychiatry, vol. 14, pp. 668–680, 1999. View at Publisher · View at Google Scholar
  5. G. M. Mckhann, L. M. Borowicz, M. A. Goldsborough, C. Enger, and O. A. Selnes, “Depression and cognitive decline after coronary artery bypass grafting,” The Lancet, vol. 349, no. 9061, pp. 1282–1284, 1997. View at Google Scholar · View at Scopus
  6. E. J. Burker, J. A. Blumenthal, M. Feldman et al., “Depression in male and female patients undergoing cardiac surgery,” British Journal of Clinical Psychology, vol. 34, no. 1, pp. 119–128, 1995. View at Google Scholar · View at Scopus
  7. Y. Shimizu, S. Yamada, F. Miyake, and T. Izumi, “The effects of depression on the course of functional limitations in patients with chronic heart failure,” Journal of Cardiac Failure, vol. 17, no. 6, pp. 503–510, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. W. Jiang, J. Alexander, E. Christopher et al., “Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure,” Archives of Internal Medicine, vol. 161, no. 15, pp. 1849–1856, 2001. View at Google Scholar · View at Scopus
  9. K. E. Joynt, D. J. Whellan, and C. M. O'Connor, “Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure,” Journal of Cardiac Failure, vol. 10, no. 3, pp. 258–271, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. P. L. P. Morris, R. G. Robinson, P. Andrzejewski, J. Samuels, and T. R. Price, “Association of depression with 10-year poststroke mortality,” American Journal of Psychiatry, vol. 150, no. 1, pp. 124–129, 1993. View at Google Scholar · View at Scopus
  11. J. C. Huffman, C. M. Celano, and J. L. Januzzi, “. The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes,” Neuropsychiatric Disease and Treatment, vol. 6, pp. 123–136, 2010. View at Google Scholar
  12. F. Lespérance, N. Frasure-Smith, M. Talajic, and M. G. Bourassa, “Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction,” Circulation, vol. 105, no. 9, pp. 1049–1053, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. A. P. Association, Diagnostic and Statistical Manual of Mental Disorders. Dsm-iv-tr, American Psychiatric Press, Washington, DC, USA, 2000.
  14. W. H. Organization, “Tenth revision of the international classification of diseases,” in Mental and behavioural disorders (including disorders of psychological development). Clinical descriptions and and diagnostic guidelines, chapter (5), WHO, 1991. View at Google Scholar
  15. A. T. Beck, C. H. Ward, M. Mendelson, J. Mock, and J. Erbaugh, “An inventory for measuring depression,” Archives of General Psychiatry, vol. 4, pp. 561–571, 1961. View at Google Scholar · View at Scopus
  16. A. T. Beck and R. A. Steer, “Internal consistencies of the original and revised Beck Depression Inventory,” Journal of Clinical Psychology, vol. 40, no. 6, pp. 1365–1367, 1984. View at Google Scholar · View at Scopus
  17. L. N. Robins, J. E. Helzer, J. Croughan, and K. S. Ratcliff, “National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity,” Archives of General Psychiatry, vol. 38, no. 4, pp. 381–389, 1981. View at Google Scholar · View at Scopus
  18. K. L. Derogatis LRaS, “The scl-90-r and brief symptom inventory (bsi) in primary care,” in Handbook of Psychological Assessment in Primary Care Settings, M. E. Maruish, Ed., Lawrence Erlbaum Associates, New York, NY, USA, 2000. View at Google Scholar
  19. A. S. Zigmond and R. P. Snaith, “The hospital anxiety and depression scale,” Acta Psychiatrica Scandinavica, vol. 67, no. 6, pp. 361–370, 1983. View at Google Scholar · View at Scopus
  20. C. A. T. Rijnders, J. F. M. van den Berg, P. P. G. Hodiamont et al., “Psychometric properties of the schedules for clinical assessment in neuropsychiatry (SCAN-2.1),” Social Psychiatry and Psychiatric Epidemiology, vol. 35, no. 8, pp. 348–352, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. M. A. Burnam, K. B. Wells, B. Leake, and J. Landsverk, “Development of a brief screening instrument for detecting depressive disorders,” Medical Care, vol. 26, no. 8, pp. 775–789, 1988. View at Google Scholar · View at Scopus
  22. W. W. Zung, “A self-rating depression scale,” Archives of General Psychiatry, vol. 12, pp. 63–70, 1965. View at Google Scholar · View at Scopus
  23. J. A. Yesavage and T. L. Brink, “Development and validation of a geriatric depression screening scale: a preliminary report,” Journal of Psychiatric Research, vol. 17, no. 1, pp. 37–49, 1982. View at Publisher · View at Google Scholar · View at Scopus
  24. L. S. Radloff, “The ces-d scale: a self report depression scale for research in the general population,” Applied Psychological Measurement, vol. 1, pp. 385–401, 1977. View at Publisher · View at Google Scholar
  25. D. P. Goldberg and V. F. Hillier, “A scaled version of the General Health Questionnaire,” Psychological Medicine, vol. 9, no. 1, pp. 139–145, 1979. View at Google Scholar · View at Scopus
  26. M. Hamilton, “A rating scale for depression,” Journal of Neurology, Neurosurgery, and Psychiatry, vol. 23, pp. 56–62, 1960. View at Google Scholar · View at Scopus
  27. M. Asberg, S. A. Montgomery, C. Perris, D. Schalling, and G. Sedvall, “A comprehensive psychopathological rating scale,” Acta Psychiatrica Scandinavica, Supplement, no. 271, pp. 5–27, 1978. View at Google Scholar · View at Scopus
  28. D. L. Hare and C. R. Davis, “Cardiac depression scale: validation of a new depression scale for cardiac patients,” Journal of Psychosomatic Research, vol. 40, no. 4, pp. 379–386, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. K. E. Joynt, D. J. Whellan, and C. M. O'Connor, “Depression and cardiovascular disease: mechanisms of interaction,” Biological Psychiatry, vol. 54, no. 3, pp. 248–261, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Schins, A. Honig, H. Crijns, L. Baur, and K. Hamulyak, “Increased coronary events in depressed cardiovascular patients: 5-HT 2A receptor as missing link?” Psychosomatic Medicine, vol. 65, no. 5, pp. 729–737, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Laghrissi-Thode, W. R. Wagner, B. G. Pollock, P. C. Johnson, and M. S. Finkel, “Elevated platelet factor 4 and β-thromboglobulin plasma levels in depressed patients with ischemic heart disease,” Biological Psychiatry, vol. 42, no. 4, pp. 290–295, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. C. B. Nemeroff, “Recent findings in the pathophysiology of depression,” Focus, vol. 6, pp. 3–15, 2008. View at Google Scholar
  33. C. B. Nemeroff and D. L. Musselman, “Are platelets the link between depression and ischemic heart disease?” American Heart Journal, vol. 140, no. 4, pp. S57–S62, 2000. View at Google Scholar · View at Scopus
  34. N. T. Mulvihill and J. B. Foley, “Inflammation in acute coronary syndromes,” Heart, vol. 87, no. 3, pp. 201–204, 2002. View at Google Scholar · View at Scopus
  35. R. Sukhija, I. Fahdi, L. Garza et al., “Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome,” American Journal of Cardiology, vol. 99, no. 7, pp. 879–884, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Manginas, A. Tsiavou, A. Chaidaroglou et al., “Inflammatory cytokine gene variants in coronary artery disease patients in Greece,” Coronary Artery Disease, vol. 19, no. 8, pp. 575–582, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Karayannis, A. Tsezou, E. Giannatou, V. Papanikolaou, G. Giamouzis, and F. Triposkiadis, “Polymorphisms of renin-angiotensin system and natriuretic peptide receptor A genes in patients of Greek origin with a history of myocardial infarction,” Angiology, vol. 61, no. 8, pp. 737–743, 2010. View at Google Scholar · View at Scopus
  38. M. B. Howren, D. M. Lamkin, and J. Suls, “Associations of depression with c-reactive protein, IL-1, and IL-6: a meta-analysis,” Psychosomatic Medicine, vol. 71, no. 2, pp. 171–186, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. A. H. Miller, V. Maletic, and C. L. Raison, “Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression,” Biological Psychiatry, vol. 65, no. 9, pp. 732–741, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. F. Buccelletti, E. Gilardi, E. Scaini et al., “Heart rate variability and myocardial infarction: systematic literature review and metanalysis,” European Review for Medical and Pharmacological Sciences, vol. 13, no. 4, pp. 299–307, 2009. View at Google Scholar · View at Scopus
  41. P. Minoretti, P. Politi, V. Martinelli et al., “QT interval duration in apparently healthy men is associated with depression-related personality trait neuroticism,” Journal of Psychosomatic Research, vol. 61, no. 1, pp. 19–23, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. R. C. Veith, N. Lewis, O. A. Linares et al., “Sympathetic nervous system activity in major depression: basal and desipramine-induced alterations in plasma norepinephrine kinetics,” Archives of General Psychiatry, vol. 51, no. 5, pp. 411–422, 1994. View at Google Scholar · View at Scopus
  43. J. M. MacKay, G. Mendis, and S. Greenlund K, The Atlas of Heart Disease and Stroke, 2004.
  44. A. Sherwood, A. L. Hinderliter, L. L. Watkins, R. A. Waugh, and J. A. Blumenthal, “Impaired endothelial function in coronary heart disease patients with depressive symptomatology,” Journal of the American College of Cardiology, vol. 46, no. 4, pp. 656–659, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Rajagopalan, R. Brook, M. Rubenfire, E. Pitt, E. Young, and B. Pitt, “Abnormal brachial artery flow-mediated vasodilation in young adults with major depression,” American Journal of Cardiology, vol. 88, no. 2, pp. 196–198, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. L. T. van Zyl, F. Lespérance, N. Frasure-Smith et al., “Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study,” Journal of Thrombosis and Thrombolysis, vol. 27, no. 1, pp. 48–56, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. S. S. Gottlieb, M. Khatta, E. Friedmann et al., “The influence of age, gender, and race on the prevalence of depression in heart failure patients,” Journal of the American College of Cardiology, vol. 43, no. 9, pp. 1542–1549, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. A. S. Malik, G. Giamouzis, V. V. Georgiopoulou et al., “Patient perception versus medical record entry of health-related conditions among patients with heart failure,” American Journal of Cardiology, vol. 107, no. 4, pp. 569–572, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. F. Cheok, G. Schrader, D. Banham, J. Marker, and A. L. Hordacre, “Identification, course, and treatment of depression after admission for a cardiac condition: rationale and patient characteristics for the Identifying Depression As a Comorbid Condition (IDACC) project,” American Heart Journal, vol. 146, no. 6, pp. 978–984, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. G. Hawthorne, J. Richardson, and R. Osborne, “The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of health-related quality of life,” Quality of Life Research, vol. 8, no. 3, pp. 209–224, 1999. View at Publisher · View at Google Scholar · View at Scopus
  51. J. E. Ware Jr. and C. D. Sherbourne, “The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection,” Medical Care, vol. 30, no. 6, pp. 473–483, 1992. View at Google Scholar · View at Scopus
  52. M. Monane, R. L. Bohn, J. H. Gurwitz, R. J. Glynn, and J. Avorn, “Noncompliance with congestive heart failure therapy in the elderly,” Archives of Internal Medicine, vol. 154, no. 4, pp. 433–437, 1994. View at Publisher · View at Google Scholar · View at Scopus
  53. M. R. DiMatteo, H. S. Lepper, and T. W. Croghan, “Depression is a risk factor for noncompliance with medical treatment meta-analysis of the effects of anxiety and depression on patient adherence,” Archives of Internal Medicine, vol. 160, no. 14, pp. 2101–2107, 2000. View at Google Scholar · View at Scopus
  54. D. L. Musselman, D. L. Evans, and C. B. Nemeroff, “The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment,” Archives of General Psychiatry, vol. 55, no. 7, pp. 580–592, 1998. View at Publisher · View at Google Scholar · View at Scopus
  55. B. Rudisch and C. B. Nemeroff, “Epidemiology of comorbid coronary artery disease and depression,” Biological Psychiatry, vol. 54, no. 3, pp. 227–240, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. B. Ruo, J. S. Rumsfeld, M. A. Hlatky, H. Liu, W. S. Browner, and M. A. Whooley, “Depressive symptoms and health-related quality of life: the Heart and Soul Study,” Journal of the American Medical Association, vol. 290, no. 2, pp. 215–221, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. W. Jiang, R. R. K. Krishnan, and C. M. O'Connor, “Depression and heart disease: evidence of a link, and its therapeutic implications,” CNS Drugs, vol. 16, no. 2, pp. 111–127, 2002. View at Google Scholar · View at Scopus
  58. J. R. Swenson, C. M. O'Connor, D. Barton et al., “Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome,” American Journal of Cardiology, vol. 92, no. 11, pp. 1271–1276, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Sherwood, J. A. Blumenthal, R. Trivedi et al., “Relationship of depression to death or hospitalization in patients with heart failure,” Archives of Internal Medicine, vol. 167, no. 4, pp. 367–373, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. C. M. O'Connor, W. Jiang, M. Kuchibhatla et al., “Antidepressant use, depression, and survival in patients with heart failure,” Archives of Internal Medicine, vol. 168, no. 20, pp. 2232–2237, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. M. M. Burg, M. C. Benedetto, R. Rosenberg, and R. Soufer, “Presurgical depression predicts medical morbidity 6 months after coronary artery bypass graft surgery,” Psychosomatic Medicine, vol. 65, no. 1, pp. 111–118, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. I. Connerney, P. A. Shapiro, J. S. McLaughlin, E. Bagiella, and R. P. Sloan, “Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study,” The Lancet, vol. 358, no. 9295, pp. 1766–1771, 2001. View at Publisher · View at Google Scholar · View at Scopus
  63. T. A. Murberg and G. Furze, “Depressive symptoms and mortality in patients with congestive heart failure: a six-year follow-up study,” Medical Science Monitor, vol. 10, no. 12, pp. CR643–CR648, 2004. View at Google Scholar · View at Scopus
  64. C. Dickens, L. McGowan, C. Percival et al., “New onset depression following myocardial infarction predicts cardiac mortality,” Psychosomatic Medicine, vol. 70, no. 4, pp. 450–455, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. P. de Jonge, R. H. S. van den Brink, T. A. Spijkerman, and J. Ormel, “Only incident depressive episodes after myocardial infarction are associated with new cardiovascular events,” Journal of the American College of Cardiology, vol. 48, no. 11, pp. 2204–2208, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. S. L. Grace, S. E. Abbey, M. K. Kapral, J. Fang, R. P. Nolan, and D. E. Stewart, “Effect of depression on five-year mortality after an acute coronary syndrome,” American Journal of Cardiology, vol. 96, no. 9, pp. 1179–1185, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. G. B. Parker, T. M. Hilton, W. F. Walsh et al., “Timing is everything: the onset of depression and acute coronary syndrome outcome,” Biological Psychiatry, vol. 64, no. 8, pp. 660–666, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. T. Spijkerman, P. de Jonge, R. H. S. van den Brink et al., “Depression following myocardial infarction: first-ever versus ongoing and recurrent episodes,” General Hospital Psychiatry, vol. 27, no. 6, pp. 411–417, 2005. View at Publisher · View at Google Scholar · View at Scopus
  69. J. Goodman, D. Shimbo, D. C. Haas, K. W. Davidson, and N. Rieckmann, “Incident and recurrent major depressive disorder and coronary artery disease severity in acute coronary syndrome patients,” Journal of Psychiatric Research, vol. 42, no. 8, pp. 670–675, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. C. M. Dickens, C. Percival, L. McGowan et al., “The risk factors for depression in first myocardial infarction patients,” Psychological Medicine, vol. 34, no. 6, pp. 1083–1092, 2004. View at Publisher · View at Google Scholar · View at Scopus
  71. H. Faller, S. Störk, M. Schowalter et al., “Depression and survival in chronic heart failure: does gender play a role?” European Journal of Heart Failure, vol. 9, no. 10, pp. 1018–1023, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. B. W. J. H. Penninx, A. T. F. Beekman, A. Honig et al., “Depression and cardiac mortality: results from a community-based longitudinal study,” Archives of General Psychiatry, vol. 58, no. 3, pp. 221–227, 2001. View at Google Scholar · View at Scopus
  73. A. Berg, H. Palomäki, M. Lehtihalmes, J. J. Lönnqvist, and M. Kaste, “Poststroke depression: an 18-month follow-up,” Stroke, vol. 34, no. 1, pp. 138–143, 2003. View at Publisher · View at Google Scholar · View at Scopus
  74. B. Poynter, M. Shuman, N. Diaz-Granados, M. Kapral, S. L. Grace, and D. E. Stewart, “Sex differences in the prevalence of post-stroke depression: a systematic review,” Psychosomatics, vol. 50, no. 6, pp. 563–569, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. K. W. Miskowiak, M. Vinberg, C. J. Harmer, H. Ehrenreich, and L. V. Kessing, “Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression,” Psychopharmacology, vol. 219, pp. 687–698, 2012. View at Publisher · View at Google Scholar
  76. A. A. Schmid, K. Kroenke, H. C. Hendrie, T. Bakas, J. M. Sutherland, and L. S. Williams, “Poststroke depression and treatment effects on functional outcomes,” Neurology, vol. 76, no. 11, pp. 1000–1005, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. C. Ellis, Y. Zhao, and L. E. Egede, “Depression and increased risk of death in adults with stroke,” Journal of Psychosomatic Research, vol. 68, no. 6, pp. 545–551, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. Group NIfHaCEGD, “The treatment and management of depression in adults,” October 2009,2012.
  79. GD Group, Depression in Adults with a Chronic Physical Health Problem: The NICE Guideline on Treatment and Management, 2009.
  80. M. M. Shores, M. Pascualy, and R. C. Veith, “Major depression and heart disease: treatment trials,” Seminars in Clinical Neuropsychiatry, vol. 3, pp. 87–101, 1998. View at Google Scholar
  81. B. H. Hansen, J. A. Hanash, A. Rasmussen, J. F. Hansen, and M. Birket-Smith, “Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD),” Trials, vol. 10, article 20, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. P. A. Shapiro, “Treatment of depression in patients with congestive heart failure,” Heart Failure Reviews, vol. 14, no. 1, pp. 7–12, 2009. View at Publisher · View at Google Scholar · View at Scopus
  83. H. J. Witchel, J. C. Hancox, and D. J. Nutt, “Psychotropic drugs, cardiac arrhythmia, and sudden death,” Journal of Clinical Psychopharmacology, vol. 23, no. 1, pp. 58–77, 2003. View at Publisher · View at Google Scholar · View at Scopus
  84. H. W. Cohen, G. Gibson, and M. H. Alderman, “Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents,” American Journal of Medicine, vol. 108, no. 1, pp. 2–8, 2000. View at Publisher · View at Google Scholar · View at Scopus
  85. S. J. Warrington, C. Padgham, and M. Lader, “The cardiovascular effects of antidepressants,” Psychological Medicine, vol. 19, no. 16, pp. 1–40, 1989. View at Google Scholar · View at Scopus
  86. Y. I. Sheline, K. E. Freedland, and R. M. Carney, “How safe are serotonin reuptake inhibitors for depression in patients with coronary heart disease?” American Journal of Medicine, vol. 102, no. 1, pp. 54–59, 1997. View at Publisher · View at Google Scholar · View at Scopus
  87. J. J. M. H. Strik, A. Honig, R. Lousberg et al., “Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial,” Psychosomatic Medicine, vol. 62, no. 6, pp. 783–789, 2000. View at Google Scholar · View at Scopus
  88. A. H. Glassman, C. M. O'Connor, R. M. Califf et al., “Sertraline treatment of major depression in patients with acute MI or unstable angina,” Journal of the American Medical Association, vol. 288, no. 6, pp. 701–709, 2002. View at Google Scholar · View at Scopus
  89. C. M. O'Connor, W. Jiang, M. Kuchibhatla et al., “Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline against depression and heart disease in chronic heart failure) trial,” Journal of the American College of Cardiology, vol. 56, no. 9, pp. 692–699, 2010. View at Publisher · View at Google Scholar · View at Scopus
  90. R. Fraguas, R. M. da Silva Telles, T. C. T. F. Alves et al., “A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms,” Contemporary Clinical Trials, vol. 30, no. 3, pp. 205–211, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. F. Lespérance, N. Frasure-Smith, D. Koszycki et al., “Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial,” Journal of the American Medical Association, vol. 297, no. 4, pp. 367–379, 2007. View at Publisher · View at Google Scholar · View at Scopus
  92. S. S. Gottlieb, W. J. Kop, S. A. Thomas et al., “A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure,” American Heart Journal, vol. 153, no. 5, pp. 868–873, 2007. View at Publisher · View at Google Scholar · View at Scopus
  93. V. K. Yeragani, V. Pesce, A. Jayaraman, and S. Roose, “Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on long-term heart rate variability measures,” Biological Psychiatry, vol. 52, no. 5, pp. 418–429, 2002. View at Publisher · View at Google Scholar · View at Scopus
  94. A. Honig, A. M. G. Kuyper, A. H. Schene et al., “Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine,” Psychosomatic Medicine, vol. 69, no. 7, pp. 606–613, 2007. View at Publisher · View at Google Scholar · View at Scopus
  95. K. B. Kerber, S. R. Wisniewski, J. F. Luther et al., “Effects of heart disease on depression treatment: results from the comed study,” General Hospital Psychiatry, vol. 34, pp. 24–34, 2012. View at Publisher · View at Google Scholar
  96. A. T. R. Beck, A. J. Shaw, and B. F. Emery G, Cognitive Therapy of Depression, Guilford Press, New York, NY, USA, 1979.
  97. G. L. Klerman, Interpersonal Psychotherapy of Depression, Basic Books, New York, NY, USA, 1984.
  98. J. C. Markowitz, G. L. Klerman, and S. W. Perry, “Interpersonal psychotherapy of depressed HIV-positive outpatients,” Hospital and Community Psychiatry, vol. 43, no. 9, pp. 885–890, 1992. View at Google Scholar · View at Scopus
  99. I. Elkin, M. T. Shea, J. T. Watkins et al., “National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments,” Archives of General Psychiatry, vol. 46, no. 11, pp. 971–983, 1989. View at Google Scholar · View at Scopus
  100. J. M. Mossey, K. A. Knott, M. Higgins, and K. Talerico, “Effectiveness of a psychosocial intervention, interpersonal counseling, for subdysthymic depression in medically ill elderly,” Journals of Gerontology A, vol. 51, no. 4, pp. M172–M178, 1996. View at Google Scholar · View at Scopus
  101. M. M. Weissman and J. C. Markowitz, “Interpersonal psychotherapy: current status,” Archives of General Psychiatry, vol. 51, no. 8, pp. 599–606, 1994. View at Google Scholar · View at Scopus